Metabolism - Clinical and Experimental
Volume 46, Issue 6 , Pages 639-643, June 1997

Pancreatic α-Cell function in idiopathic reactive hypoglycemia☆☆

  • Saeid Ahmadpour

      Affiliations

    • Veterans Affairs Medical Center, Des Moines, IA, USA
    • Veterans Affairs Medical Center, Phoenix, AZ, USA
    • University of Arizona School of Medicine, Tucson, AZ, USA
  • ,
  • Udaya M. Kabadi

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Udaya M. Kabadi, MD, 1919 Darien Club Dr, Darien, IL 60561.
    • Veterans Affairs Medical Center, Des Moines, IA, USA
    • Veterans Affairs Medical Center, Phoenix, AZ, USA
    • University of Arizona School of Medicine, Tucson, AZ, USA

Received 22 February 1996; accepted 2 December 1996.

Abstract 

Idiopathic reactive hypoglycemia (IRH) is a well-documented but overdiagnosed syndrome. The presence of transient hypoglycemia and enhanced insulin secretion and/or increased insulin sensitivity before the onset of IRH is well documented. However, the data regarding glucagon secretion are sparse. Therefore, this study assessed glucagon and insulin responses to (1) oral ingestion of 100 g glucose oral glucose tolerance test (OGTT) and (2) a 100-g protein meal after an overnight fast in a randomized sequence at intervals of 7 to 10 days in five subjects with previously well-documented IRH and six normal subjects. Basal plasma glucose and insulin levels were not significantly different in both groups. However, basal glucagon was significantly higher (P < .025) in IRH subjects (347 ± 83 ng/L) compared with normals (135 ± 20 ng/L). In IRH subjects during the OGTT, hypoglycemia (2.7 ± 0.11 mmol/L) occurred at 150 ± 16 minutes and was preceded by a markedly higher (P < .01) peak glucose concentration (11.7 ± 0.6 mmol/L) at 36 ± 6 minutes in comparison to normals (8.8 ± 0.4 mmol/L), indicating the presence of impaired glucose tolerance in these subjects. Similarly, the plasma insulin increase was significantly higher (P < .01) but delayed in IRH subjects compared with normals. In contrast, glucagon suppression was not significantly different in both groups, although glucagon failed to increase following hypoglycemia in IRH. During a protein meal, plasma glucose declined in both groups, with a significantly (P < .05) greater decrease in IRH subjects (−0.8 ± 0.2 mmol/L) compared with normals (0.5 ± 0.1 mmol/L). However, the glucagon increase was significantly (P < .01) blunted in IRH subjects (61% ± 15%) in comparison to normals (152% ± 39%). Thus, basal hyperglucagonemia with normal glucose concentration may suggest the presence of a hyposensitivity of the glucagon receptor in IRH. Moreover, the lack of appropriate suppression during the OGTT despite marked hyperglycemia, the lack of an increase at the onset of hypoglycemia, and the inhibited response to a protein meal in IRH subjects compared with normals denote altered glucagon secretion in IRH. Therefore, it is likely that glucagon receptor downregulation and impaired glucagon sensitivity and secretion may contribute to postprandlal hypoglycemia in IRH.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by a research grant from the Department of Veterans Affairs, Washington, DC, and the Survarnam Foundation, Des Moines, IA.

☆☆ Presented in part at the Annual Meeting of The Endocrine Society, Washington, DC, June 1995.

PII: S0026-0495(97)90006-8

Metabolism - Clinical and Experimental
Volume 46, Issue 6 , Pages 639-643, June 1997